565 related articles for article (PubMed ID: 3881821)
1. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
[TBL] [Abstract][Full Text] [Related]
2. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
3. [Insulin autoantibodies and islet cell antibodies in recently appearing diabetes mellitus type I. Association with age of manifestation and HLA phenotype].
Ziegler AG; Rabl W; Albert E; Standl E
Dtsch Med Wochenschr; 1991 Nov; 116(46):1737-41. PubMed ID: 1935660
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
5. [Diabetes mellitus type I, thyroid gland autoimmunity, thyroid gland function and HLA status].
Kehr S; Gastauer R; Winkler G
Monatsschr Kinderheilkd; 1985 Oct; 133(10):738-42. PubMed ID: 3906379
[TBL] [Abstract][Full Text] [Related]
6. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
7. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
8. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
9. Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies.
Robles DT; Eisenbarth GS; Wang T; Erlich HA; Bugawan TL; Babu SR; Barriga K; Norris JM; Hoffman M; Klingensmith G; Yu L; Rewers M;
Clin Immunol; 2002 Mar; 102(3):217-24. PubMed ID: 11890708
[TBL] [Abstract][Full Text] [Related]
10. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
[TBL] [Abstract][Full Text] [Related]
11. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
12. The genetics of Type 1 (insulin-dependent) diabetes.
Cudworth AG; Wolf E
Curr Probl Clin Biochem; 1983; 12():45-64. PubMed ID: 6418443
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease].
Schilling I; Conrad K; Füssel M; Henker J
Dtsch Med Wochenschr; 2003 Jan; 128(5):185-9. PubMed ID: 12557109
[TBL] [Abstract][Full Text] [Related]
14. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
15. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
Ferber KM; Keller E; Albert ED; Ziegler AG
J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
[TBL] [Abstract][Full Text] [Related]
17. HLA and autoimmune endocrine disease 1985.
Farid NR; Thompson C
Mol Biol Med; 1986 Feb; 3(1):85-97. PubMed ID: 3485759
[TBL] [Abstract][Full Text] [Related]
18. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus.
Ayed K; Bardi R; Gorgi Y; Jenhani F; Chammakhi S; Boukhris R
Dis Markers; 1989; 7(1):43-7. PubMed ID: 2714046
[TBL] [Abstract][Full Text] [Related]
19. The HLA association of insulin-dependent (type I) diabetes mellitus.
Bertrams J
Behring Inst Mitt; 1984 Jul; (75):89-99. PubMed ID: 6333238
[TBL] [Abstract][Full Text] [Related]
20. High risk HLA-DR/DQ genotypes for IDD confer susceptibility to autoantibodies but DQB1*0602 does not prevent them.
Huang W; She JX; Muir A; Laskowska D; Zorovich B; Schatz D; Maclaren NK
J Autoimmun; 1994 Dec; 7(6):889-97. PubMed ID: 7888045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]